AI and Better Assays Are Closing Acromegaly's 10-Year Diagnostic Gap
Acromegaly goes undiagnosed for up to a decade. New AI tools and refined hormone assays may finally change that.
Hormonal health, testosterone, estrogen, thyroid, cortisol, and endocrine research
213 articoli
Acromegaly goes undiagnosed for up to a decade. New AI tools and refined hormone assays may finally change that.
A landmark multi-omics study maps how the ovary, uterus, and vagina age on distinct timelines, with menopause as a critical inflection point.
New research argues stress-induced testosterone drops are a central brain adaptation, not testicular failure — with major clinical implications.
A 135-patient pediatric study finds obesity and short stature dominate BBS, while hypogonadism and hypothyroidism remain rare in childhood.
A systematic review of 9 studies finds FSH improves sperm count and motility in normogonadotropic men, but pregnancy benefits remain unproven.
Pituitary adenoma receptor profiles and granulation patterns determine which somatostatin drugs work best for acromegaly patients.
A major review updates clinicians on managing acromegaly's wide-ranging complications, from heart disease to cancer risk.
A comprehensive review reveals that fatigue, pain, and impaired quality of life persist in acromegaly patients even after hormones are normalized.
A real-world validation of updated thyroid cancer risk guidelines finds a major reclassification shift — with a newly defined middle-risk group needing closer study.
Deep Dive nella cascata di segnalazione del fattore di crescita insulino-simile e nel suo duplice ruolo nel promuovere la crescita pur potendo limitare l'aspettativa di vita.
Scopri perché gli ormoni che ci aiutano a crescere e a costruire massa muscolare potrebbero anche accelerare l'invecchiamento, e cosa significa questo per la tua salute.
New research reveals how polycystic ovary syndrome disrupts immune cells and neurotransmitters, potentially increasing gynecological cancer risk.